Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Ascending Dose Study to Determine the Safety and Attack Rate of a Wild Type, Seasonal H3N2 Influenza Challenge Agent in Healthy Volunteers

NCT04372719 is registered in ClinicalTrials.gov with SGS Life Sciences, a division of SGS Belgium NV as lead sponsor.

NCT NCT04372719
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04372719 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Ascending Dose Study to Determine the Safety and Attack Rate of a Wild Type, Seasonal H3N2 Influenza Challenge Agent in Healthy Volunteers
Lead sponsor
SGS Life Sciences, a division of SGS Belgium NV
Phase
Phase 1
Overall status
Completed
Start date
November 2, 2016
Completion date
December 28, 2016
Enrollment
36 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

influenza, human